» Articles » PMID: 21045807

FoxO1 Regulates Tlr4 Inflammatory Pathway Signalling in Macrophages

Overview
Journal EMBO J
Date 2010 Nov 4
PMID 21045807
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

The macrophage-mediated inflammatory response is a key etiologic component of obesity-related tissue inflammation and insulin resistance. The transcriptional factor FoxO1 is a key regulator of cell metabolism, cell cycle and cell death. Its activity is tightly regulated by the phosphoinositide-3-kinase-AKT (PI3K-Akt) pathway, which leads to phosphorylation, cytoplasmic retention and inactivation of FoxO1. Here, we show that FoxO1 promotes inflammation by enhancing Tlr4-mediated signalling in mature macrophages. By means of chromatin immunoprecipitation (ChIP) combined with massively parallel sequencing (ChIP-Seq), we show that FoxO1 binds to multiple enhancer-like elements within the Tlr4 gene itself, as well as to sites in a number of Tlr4 signalling pathway genes. While FoxO1 potentiates Tlr4 signalling, activation of the latter induces AKT and subsequently inactivates FoxO1, establishing a self-limiting mechanism of inflammation. Given the central role of macrophage Tlr4 in transducing extrinsic proinflammatory signals, the novel functions for FoxO1 in macrophages as a transcriptional regulator of the Tlr4 gene and its inflammatory pathway, highlights FoxO1 as a key molecular adaptor integrating inflammatory responses in the context of obesity and insulin resistance.

Citing Articles

Metformin as a strategy against false positives in F-FDG PET/CT due to inflammation.

Feng Y, Xiang X, Weng Y, Xia B, Li H, Li Y Heliyon. 2024; 10(23):e40269.

PMID: 39687197 PMC: 11647850. DOI: 10.1016/j.heliyon.2024.e40269.


MicroRNAs as Epigenetic Regulators of Obesity.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:595-627.

PMID: 39287866 DOI: 10.1007/978-3-031-63657-8_20.


Quercetin inhibited LPS-induced cytokine storm by interacting with the AKT1-FoxO1 and Keap1-Nrf2 signaling pathway in macrophages.

Xu J, Li Y, Yang X, Li H, Xiao X, You J Sci Rep. 2024; 14(1):20913.

PMID: 39245773 PMC: 11381534. DOI: 10.1038/s41598-024-71569-y.


The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression.

Xu D, Qu X, Yang T, Sheng M, Bian X, Zhan Y Exp Mol Med. 2024; 56(8):1843-1855.

PMID: 39122845 PMC: 11372114. DOI: 10.1038/s12276-024-01280-5.


MOCHA's advanced statistical modeling of scATAC-seq data enables functional genomic inference in large human cohorts.

Zaim S, Pebworth M, McGrath I, Okada L, Weiss M, Reading J Nat Commun. 2024; 15(1):6828.

PMID: 39122670 PMC: 11316085. DOI: 10.1038/s41467-024-50612-6.


References
1.
Su D, Coudriet G, Kim D, Lu Y, Perdomo G, Qu S . FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. Diabetes. 2009; 58(11):2624-33. PMC: 2768186. DOI: 10.2337/db09-0232. View

2.
Kops G, Burgering B . Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med (Berl). 1999; 77(9):656-65. DOI: 10.1007/s001099900050. View

3.
de Luca C, Olefsky J . Inflammation and insulin resistance. FEBS Lett. 2007; 582(1):97-105. PMC: 2246086. DOI: 10.1016/j.febslet.2007.11.057. View

4.
Tothova Z, Kollipara R, Huntly B, Lee B, Castrillon D, Cullen D . FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007; 128(2):325-39. DOI: 10.1016/j.cell.2007.01.003. View

5.
Shi H, Kokoeva M, Inouye K, Tzameli I, Yin H, Flier J . TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116(11):3015-25. PMC: 1616196. DOI: 10.1172/JCI28898. View